Promising new radiation drug targets Hard-to-Treat prostate cancer
NCT ID NCT05720130
First seen Feb 22, 2026 · Last updated Apr 24, 2026 · Updated 7 times
Summary
This study tests a new drug that delivers a type of radiation directly to prostate cancer cells that have spread. It is for men with metastatic prostate cancer that is no longer controlled by hormone therapy. The goal is to find the safest and most effective dose and to see if it can shrink tumors or slow the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Gold Coast University Hospital
RECRUITINGSouthport, Queensland, 4215, Australia
Contact
-
Princess Alexandra Hospital
RECRUITINGBrisbane, Queensland, 4102, Australia
Contact
-
Royal Brisbane & Women's Hospital
RECRUITINGBrisbane, Queensland, 4029, Australia
Contact
Conditions
Explore the condition pages connected to this study.